Hematologically important mutations: Band 3 and protein 4.2 variants in hereditary spherocytosis

Blood Cells, Molecules and Diseases

Volumn 23, Issue 3, 1997, Pages 417-421

  Gallagher, Patrick G ^a   Forget, Bernard G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERYTHROCYTE MEMBRANE; GENE MUTATION; HEREDITARY SPHEROCYTOSIS; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0031417692     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1997.0160     Document Type: Article

References (37)

1. Becker P, Lux S. Disorders of the red cell membrane skeleton: Hereditary spherocytosis and hereditary elliptocytosis. The Metabolic Basis of Inherited Disease. 1995;McGraw-Hill, New York. p. 529-632.
2. Gallagher P G, Ferriera J D. Molecular basis of erythrocyte membrane disorders. Curr Opin Hematol. 4:1997;128-135.
3. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev. 10:1996;129-147.
4. Delaunay J. Genetic disorders of the red cell membranes. FEBS Lett. 369:1995;34-37.
5. Lux S E, Palek J. Disorders of the red cell membrane. Handin R I, Lux S E, Stossel T P. Blood: Principles and Practice of Hematology. 1995;1701-1816 JB Lippincott, Philadelphia.
6. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol. 30:1993;249-283.
7. Wang D N. B and 3 protein: structure, flexibility and function. FEBS Lett. 346:1994;26-31.
8. Tanner M J. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol. 30:1993;34-57.
9. Bruce L J, Tanner M J. Structure-function relationships of band 3 variants. Cell Mol Biol (Noisy-Le-Grand). 42:1996;953-973.
10. Yawata Y. Red cell membrane protein band 4.2: phenotypic, genetic and electron microscopic aspects. Biochim Biophys Acta. 1204:1994;131-148.
11. Cohen C M, Dotimas E, Korsgren C. Human erythrocyte membrane protein band 4.2 (pallidin). Semin Hematol. 30:1993;119-137.
12. Jarolim P, Palek J, Rubin H L, Prchal J T, Korsgren C, Cohen C M. Band 3 Tuscaloosa: Pro327 - -Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2. Blood. 80:1992;523-529.
13. Rybicki A C, Qiu J J, Musto S, Rosen N L, Nagel R L, Schwartz R S. Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid→lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore). Blood. 81:1993;2155-2165.
14. Lux S E, John K M, Kopito R R, Lodish H F. Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). Proc Natl Acad Sci USA. 86:1989;9089-9093.
15. Sung L A, Chien S, Chang L S. Molecular cloning of human protein 4.2: a major component of the erythrocyte membrane. Proc Natl Acad Sci USA. 87:1990;955-959.
16. Beutler E, McKusick V A, Motulsky A G, Scriver C R, Hutchinson F. Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat. 8:1996;203-206.
17. Miraglia del Giudice E, Vallier A, Maillet P. Novel band 3 variants (bands 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency: status of the D38A polymorphism within the EPB3 locus. Br J Haematol. 96:1997;70-76.
18. Kanzaki A, Takezono M, Kaku M. Molecular and genetic characteristics in Japanese patients with hereditary spherocytosis: frequent band 3 mutations and rarer ankyrin mutations. Blood. 90:1997;6b.
19. Jarolim P, Murray J L, Rubin H L. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 88:1996;4366-4374.
20. Eber S W, Gonzalez J M, Lux M L. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet. 13:1996;214-218.
21. Alloisio N, Maillet P, Carre G. Hereditary spherocytosis with band 3 deficiency. Association with a nonsense mutation of the band 3 gene (allele Lyon), and aggravation by a low-expression allele occurring in trans (allele Genas). Blood. 88:1996;1062-1069.
22. Lima P RM, Gontijo J AR, Lopes de Faria J B, Costa F F, Saad S TO. Band 3 Campinas: a novel splicing mutation in the band 3 gene (AE1) associated with hereditary spherocytosis, hyperactivity of Na+/Li+ countertransport and an abnormal renal bicarbonate handling. Blood. 90:1997;2810-2818.
23. Dhermy D, Galand C, Bournier O. Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects. Br J Haematol. 98:1997;32-40.
24. Jenkins P B, Abou-Alfa G K, Dhermy D. A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis. J Clin Invest. 97:1996;373-380.
25. Alloisio N, Texier P, Vallier A. Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis. Blood. 90:1997;414-420.
26. Bianchi P, Zanella A, Alloisio N. A variant of the EPB3 gene of the anti-Lepore type in hereditary spherocytosis. Br J Haematol. 98:1997;283-288.
27. Jarolim P, Rubin H L, Brabec V. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood. 85:1995;634-640.
28. Maillet P, Vallier A, Reinhart W H. Band 3 Chur: a variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11. Br J Haematol. 91:1995;804-810.
29. Jarolim P, Rubin H L, Liu S C. Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE). J Clin Invest. 93:1994;121-130.
30. Perrotta S, Nigro V, Polito R, Nobili B. Hereditary spherocytosis due to an elongated band 3: Band 3 Vesuvio. Blood. 90:1997;270a.
31. Hayette S, Dhermy D, dos Santos M E. A deletional frameshift mutation in protein 4.2 gene (allele 4.2 Lisboa) associated with hereditary hemolytic anemia. Blood. 85:1995;250-256.
32. Takaoka Y, Ideguchi H, Matsuda M, Sakamoto N, Takeuchi T, Fukumaki Y. A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka). Br J Haematol. 88:1994;527-533.
33. Bouhassira E E, Schwartz R S, Yawata Y. An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4.2 NIPPON). Blood. 79:1992;1846-1854.
34. Kanzaki A, Yawata Y, Yawata A. Band 4.2 Komatsu: 523 GAT→TAT (175 Asp→Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network. Int J Hematol. 61:1995;165-178.
35. Notame. Hum Mol Genet. 4:1995;1187-1191.
36. Hayette S, Morle L, Bozon M. A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia. Br J Haematol. 89:1995;762-770.
37. Kanzaki A, Yasunaga M, Okamoto N. Band 4.2 shiga: 317 CGC→TGC in compound heterozygotes with 142 GCT→ACT results in band 4.2 deficiency and microspherocytosis. Br J Haematol. 91:1995;333-340.